• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number OP-05W(A)
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Shock (2072)
Event Date 10/11/2018
Event Type  Injury  
Manufacturer Narrative
This incident occurred in (b)(6) and we are reporting this event since we consider the severity of the event is serious injury as the patient experienced shock and causal relationship between this device and the event could not be denied because the event happened during the immunoadsorption plasmapheresis therapy.We are unable to investigate since the actual used medical device was not returned to us and the lot number was unknown.The root cause could not be identified.The adverse event may have been caused by clinical condition of the patient.
 
Event Description
The female patient with primary disease of myasthenia gravis experienced following adverse event during immunoadsorption plasmapheresis treatment.The patient received the first immunoadsorption plasmapheresis therapy on (b)(6) 2018 and the second therapy on (b)(6) 2018 with no issue.On (b)(6) 2018, the third therapy was given to the patient.The patient blood pressure was between 110 and 120 mmhg and heart rate was 60 bpm before the therapy.34 minutes after the therapy was started, her blood pressure was decreased to 100 mmhg.41 minutes after the therapy was started, she complained of epigastric pain.Since the blood pressure was decreased to 58 mmhg and heart rate was also decreased to between 30 to 40 bpm, 300 ml of normal saline was administered.After the administration of normal saline, the patient blood pressure was increased to 100 mmhg temporarily, but it was decreased again to 70 mmhg and consciousness level was dropped.To treat the symptoms, oxygen therapy was administered at 1l/min.49 minutes after the treatment was started, the blood pressure was increased to 126 mmhg and level of consciousness was recovered.The blood was returned to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
oita works
2111-2 oaza sato
oita-shi, oita, 870-0 396
JA   870-0396
Manufacturer Contact
akitake yamashita
1-1-2 yurakucho, chiyoda-ku
tokyo, 100-0-006
JA   100-0006
MDR Report Key8050026
MDR Text Key126508463
Report Number8010002-2018-00200
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberOP-05W(A)
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/12/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
IMMUSORBA TR-350
Patient Outcome(s) Congenital Anomaly; Hospitalization; Other; Required Intervention; Disability;
Patient Age83 YR
Patient Weight49
-
-